Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,495
Closed -$153K 1848
2024
Q4
$153K Sell
15,495
-29,216
-65% -$200K ﹤0.01% 1381
2024
Q3
$178K Buy
+44,711
New +$191K ﹤0.01% 1468
2024
Q2
Sell
-20,823
Closed -$72K 1847
2024
Q1
$72K Buy
+20,823
New +$79.2K ﹤0.01% 1427
2023
Q2
Sell
-11,600
Closed -$54K 2143
2023
Q1
$54K Buy
+11,600
New +$41.9K ﹤0.01% 1658
2022
Q1
Sell
-24,936
Closed -$160K 2549
2021
Q4
$160K Sell
24,936
-20,046
-45% -$145K ﹤0.01% 1871
2021
Q3
$620K Sell
44,982
-34,378
-43% -$514K 0.01% 1269
2021
Q2
$1.18M Buy
79,360
+57,305
+260% +$962K 0.01% 918
2021
Q1
$393K Sell
22,055
-6,417
-23% -$125K 0.01% 1510
2020
Q4
$407K Buy
+28,472
New +$348K ﹤0.01% 1372
2019
Q3
Sell
-10,200
Closed -$160K 1550
2019
Q2
$160K Buy
+10,200
New +$183K 0.01% 970

Other funds holding OMER

Michael Gelband's OMER Position: Q1 2025 in Review

Michael Gelband sold out of Omeros (OMER) in Q1 2025, closing a stake of 15,495 shares — an estimated $153K sold.

Michael Gelband first reported a position in OMER in Q2 2019 and held it in 10 quarters. The position peaked at $1.18M in Q2 2021. 136 funds tracked by Wall St. Rank hold OMER as of Q1 2025.

  • Michael Gelband reported no remaining Omeros position as of Q1 2025 after selling out during the quarter.
  • Michael Gelband sold 15,495 Omeros shares in Q1 2025, an estimated $153K.
  • Michael Gelband first reported a position in Omeros in Q2 2019 and held it in 10 quarters.
  • Michael Gelband's Omeros position peaked at $1.18M in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Omeros as of Q1 2025.

Based on ExodusPoint Capital Management's 13F filing for Q1 2025, filed 14 May 2025.